Cancer Screening No Audio (1).pdf

Cancer Prevention in Adults Agenda      Cervical Cancer  HPV (Human Papilloma Virus) is the biggest risk factor for the development of cervical cancer and is present in the vast majority of cases of cervical cancer  Cervical cancer mortality has dramatically decreased with routine screening....

Cancer Prevention in Adults Agenda      Cervical Cancer  HPV (Human Papilloma Virus) is the biggest risk factor for the development of cervical cancer and is present in the vast majority of cases of cervical cancer  Cervical cancer mortality has dramatically decreased with routine screening. There is a long latency period from the time of an initial lesion to the development of cervical cancer.  Screening tests include cytology (Papanicolaou or "Pap" smear), HPV testing for high risk strains, or combined cytology and HPV testing (co-testing). Cervical Cancer Screening  The USPSTF currently recommends that women aged 21–29 be screened with cervical cytology (PAP smear) every 3 years.  There is a high rate of cleared HPV in this age group and so routine HPV testing is not recommended.  Women aged 30–65 can be screened with cervical cytology alone every 3 years, HPV testing alone every 5 years, or co-testing every 5 years.  Women who do not need cervical cancer screening include Women younger than age 21 Women who have had a hysterectomy with removal of the cervix and who do not have history of cervical cancer or CIN2 or 3 Women aged 65 and older who have a history of adequate screening and are not otherwise at high risk Lung Cancer Screening   Colorectal Cancer Screening Adults aged 50 to 75 years The USPSTF recommends screening for colorectal cancer in all adults aged 50 to 75 years. See the "Practice Considerations" section and Table 1 for details about screening strategies. A Adults aged 45 to 49 years The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years. See the "Practice Considerations" section and Table 1 for details about screening strategies. B Adults aged 76 to 85 years The USPSTF recommends that clinicians selectively offer screening for colorectal cancer in adults aged 76 to 85 years. Evidence indicates that the net benefit of screening all persons in this age group is small. In determining whether this service is appropriate in individual cases, patients and clinicians should consider the patient's overall health, prior screening history, and preferences. C Colorectal Cancer Screening Testing Stool Tests The guaiac-based fecal occult blood test (gFOBT) uses the chemical guaiac to detect blood in the stool. Done once a year The fecal immunochemical test (FIT) uses antibodies to detect blood in the stool. It is also done once a year in the same way as a gFOBT. The FIT-DNA test (also referred to as the stool DNA test) combines the FIT with a test that detects altered DNA in the stool. It is done once every three years. Flexible Sigmoidoscopy  A short, thin, flexible, lighted scope is placed into the rectum. Looking for polyps or cancer inside the rectum and lower third of the colon.  How often: Every 5 years, or every 10 years with a FIT every year. Colonoscopy  A longer, thin, flexible, lighted tube to check for polyps or cancer inside the rectum and the entire colon. During this test, you can find and remove most polyps and some cancers. Colonoscopy also is used as a follow -up test if anything unusual is found during one of the other scree ning tests.  How often: Every 10 years (for people who do not have an increased risk of colorectal cancer). CT Colonography (Virtual Colonoscopy)  Computed tomography (CT) colonography, also called a virtual colonoscopy, uses X -rays and computers to produce images of the ent ire colon, which are displayed on a computer screen for the doctor to analyze.  How often: Every 5 years. Prostate Cancer Screening Thank you